Gregg A. Olsen
- Oncology top 10%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Neurology top 10%
- Cancer Research
- Co-authors
- Robert C. BastJon P. GockermanW. P. PetersR B JonesE.J. ShpallJ O MooreEarl R. KernJames C. Overall
- Topics
- Cytomegalovirus and herpesvirus research (5 papers)Lymphoma Diagnosis and Treatment (4 papers)Neutropenia and Cancer Infections (3 papers)
- Partner nations
- United States
In The Last Decade
Gregg A. Olsen
17 papers receiving 710 citations
Peers
Comparison fields: 5 of 74
- Oncology 417
- Hematology 213
- Pathology and Forensic Medicine 205
- Neurology 135
- Cancer Research 133
Countries citing papers authored by Gregg A. Olsen
This map shows the geographic impact of Gregg A. Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg A. Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg A. Olsen more than expected).
Fields of papers citing papers by Gregg A. Olsen
This network shows the impact of papers produced by Gregg A. Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg A. Olsen. The network helps show where Gregg A. Olsen may publish in the future.
Co-authorship network of co-authors of Gregg A. Olsen
This figure shows the co-authorship network connecting the top 25 collaborators of Gregg A. Olsen. A scholar is included among the top collaborators of Gregg A. Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg A. Olsen. Gregg A. Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 63 | |
| 3 | 95 | |
| 4 | 1 | |
| 5 | Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. | 7 |
| 6 | 22 | |
| 7 | 317 | |
| 8 | 38 | |
| 9 | Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. | 61 |
| 10 | Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. | 9 |
| 11 | 29 | |
| 12 | Mitoxantrone in the treatment of relapsed and refractory acute leukemia. | 33 |
| 13 | Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber. | 1 |
| 14 | 8 | |
| 15 | 22 | |
| 16 | 22 | |
| 17 | 21 |
About Gregg A. Olsen
Gregg A. Olsen is a scholar working on Parasitology, Immunology and Pathology and Forensic Medicine, having authored 17 papers that have together received 752 indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (213 citations), Oncology (417 citations) and Pathology and Forensic Medicine (205 citations). Gregg A. Olsen has collaborated with scholars based in United States. Frequent co-authors include Robert C. Bast, Jon P. Gockerman, W. P. Peters, R B Jones, E.J. Shpall, J O Moore, Earl R. Kern, James C. Overall, Andres Forero‐Torres and Robert Chen. Their work appears in journals such as Journal of Clinical Oncology, Blood and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.